Moberg Pharma AB (MBGPF)
1.10
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Moberg Pharma Profit Margin (Quarterly) : -56.91% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -56.91% |
| March 31, 2026 | -25.66% |
| December 31, 2025 | -616.9% |
| September 30, 2025 | -107.8% |
| June 30, 2025 | -205.6% |
| March 31, 2025 | -71.59% |
| December 31, 2024 | -23.68K% |
| September 30, 2024 | -32.71% |
| June 30, 2024 | -98.47% |
| March 31, 2024 | -792.1% |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | -2.06K% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| June 30, 2019 | |
| March 31, 2019 | 18.47% |
| December 31, 2018 | 11.29% |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 10.61% |
| September 30, 2017 | 11.41% |
| June 30, 2017 | -5.71% |
| March 31, 2017 | -2.87% |
| December 31, 2016 | -2.77% |
| September 30, 2016 | 12.29% |
| June 30, 2016 | 39.27% |
| March 31, 2016 | -8.13% |
| December 31, 2015 | 0.73% |
| September 30, 2015 | 13.18% |
| June 30, 2015 | 5.92% |
| March 31, 2015 | 14.91% |
| December 31, 2014 | -0.59% |
| September 30, 2014 | 8.74% |
| June 30, 2014 | 7.05% |
| March 31, 2014 | 8.52% |
| December 31, 2013 | -1.16% |
| September 30, 2013 | -10.55% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Orexo AB | -2.93K% |
| Swedencare AB | 3.54% |
| Camurus AB | 34.30% |
| Infant Bacterial Therapeutics AB | -- |
| AstraZeneca PLC | 20.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -3.25% |
| Return on Assets | -3.16% |
| Return on Invested Capital | -3.24% |
| Gross Profit Margin (Quarterly) | 65.36% |
| Operating Margin (Quarterly) | -125.8% |
| Return on Net Operating Assets | -6.00% |